Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Golden Grand Bio-Tech Co., Ltd. is a prominent Chinese biotechnology and chemical manufacturing company specializing in the large-scale production of amino acids and pharmaceutical intermediates. Established in 1986 and headquartered in Shijiazhuang, Hebei Province, the company is widely recognized as one of the world's largest producers of glycine, offering pharmaceutical (USP), food, and industrial grades. Their portfolio includes essential amino acids such as L-threonine and L-valine, which serve as critical building blocks for the pharmaceutical, nutraceutical, and animal feed industries. The company operates sophisticated manufacturing facilities that integrate advanced fermentation and chemical synthesis technologies under strict GMP and ISO quality standards. Golden Grand functions as a key supplier for the production of intravenous infusions and various synthetic drug applications globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Golden Grand Bio-Tech.